Massachusetts Ear

Mass Eye and Ear is a world-renowned specialty hospital and research center located in Boston, Massachusetts, dedicated to ophthalmology and otolaryngology. As a primary teaching hospital of Harvard Medical School, it conducts pioneering research that has led to major medical breakthroughs, including the development of the first FDA-approved gene therapy for an inherited disease and the first anti-VEGF treatments for macular degeneration. The institution provides comprehensive clinical care for complex disorders of the eye, ear, nose, throat, and head and neck. In 2018, it officially joined the Mass General Brigham healthcare system, further integrating its clinical and research excellence into a broader network. Mass Eye and Ear remains a global leader in sensory loss research, operating one of the largest vision and hearing research communities in the world.